The following is not a comprehensive list.
Posted May 3, 2016
CROSS sectional study of cardiovascular Function and risk profiles
In BRCA muTation carriers (CROSSFIT Study)
You have previously been tested and found to have a gene alteration called ‘BRCA mutation’, which increases the chance of certain kinds of cancer. Scientists are now wondering if the BRCA mutation might also increase the chance of other health problems, such as the heart or blood vessels, called ‘cardiovascular’ disease.
We would like to perform several tests to study your cardiovascular system in detail. In this way, we will learn about risk factors in people with the BRCA mutation, and how to develop the best ways to help.
If you have any questions or concerns, please contact the investigators: Edith Pituskin PhD at 780-432-8221, Barbara Krause MD at 780-432-8518 or Ian Paterson MD at 780-407-1857. If you have any questions regarding your rights as a research participant, you may contact the Health Research Ethics Board at 780-492-2615. This office is independent of the study investigators.
Posted April 25, 2016
University of Hartford. Graduate Institute of Professional Psychology. The purpose of this study is to gain a better understanding of how psychotherapy can be helpful to women after finding out their positive BRCA 1 and/or 2 status.
Posted December 3, 2015
SURVEY: Researchers at the University of Toronto are conducting an online survey to understand what breast cancer survivors need to be more active. For example, do you feel you need more opportunities to be active? Are you missing an exercise partner? Do you want more available programs? If you are a woman who has been diagnosed with breast cancer and:
- you have completed treatment (not including hormonal therapy)
- you are not active, but want to be OR
- you are active, but want to increase your activity levels
- you have 20-25 minutes to complete this important online survey
You can help us, help you!
Please complete the questionnaire at www.icanbeactive.com. Your answers will help to develop physical activity materials and opportunities to help more women be more active.
Posted October 2, 2015
STUDY PARTICIPANTS NEEDED: Follow-up Telephone Genetic Counselling Study
In collaboration with Dr. Kelly Metcalfe at Women’s College Hospital (Toronto, Canada) we are inviting women with a BRCA1/2 mutation to participate in a clinical trial. Through this study, a genetic counsellor will provide up-to-date follow-up information about cancer risk management over the telephone. For those that meet eligibility criteria, participation involves the following: Completion of two (2) questionnaires; and a scheduled genetic counselling session over the telephone. More information: www.kellymetcalfe.ca/research/phonegcstudy/
Posted October 1, 2015
STUDY OF CANCER SURVEILLANCE AND PREVENTION PRACTICES ASSOCIATED WITH BRCA1 AND BRCA2 MUTATIONS
The purpose of this study is to better understand patient experience of the surveillance and prevention practices associated with genetic risk for breast and ovarian cancers
Who Is Eligible?
- Women over age 18 who have been diagnosed with a BRCA1 or BRCA2 mutation but do not have cancer.
What Will You Be Asked To Do?
- This study asks you to participate in either in a 60-90 minute phone interview or in a written interview (questions exchanged via email) at a date and time of your choosing.
If you have any questions or are interested in participating in this study, please contact Dr. Kelly Pender, Associate Professor of English at Virginia Tech, at 540-808-9563 or firstname.lastname@example.org
Posted March 23, 2015
STUDY PARTICIPANTS NEEDED: Study for Early Detection of Ovarian Cancer. This study is being conducted by MD Anderson for the early detection of ovarian cancer, and they recently got funding to add another 1,000 women. Currently, there are about 5,000 women in the study around the country. Veronica Solano is the Sr. Research Data Coordinator for this study. Her email is Vsolano@mdanderson.org and her phone number is 713-512-7789. Her office is at 7900 Fannin, Ste. 4000. To participate in this study your blood will be drawn once a year. There is no cost to participate in the study. Other requirements are: Ages – 50 – 74. Post-menopausal (no period for one year or longer) Not under cancer treatment for the past 12 months Have at least one ovary and have a healthcare provider.
Current Studies at the Women’s College Research Institute, Toronto
Canadian Clinical trials: http://ctdb-bdec.hc-sc.gc.ca/ctdb-bdec/index-eng.jsp | http://www.canadiancancertrials.ca/
Canadian Breast Cancer Trials ttps://www.breastcancertrials.org/bct_nation/home.seam
UBRCA-specific Trials: Clinicaltrials.gov
UK Clinical Trial Gateway: http://www.ukctg.nihr.ac.uk/default.aspx
Australian Clinical Trials: http://www.anzctr.org.au/
National Cancer Institute Breast Cancer Trials: http://www.cancer.gov/clinicaltrials
Women’s Institute Canada: